Survey study measured factors that affect levels of distress and uncertainty in a diverse population of patients undergoing multigene hereditary cancer testing.
A panel of experts agreed that men with metastatic prostate cancer may be the most appropriate candidates for comprehensive genetic testing.
New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of hereditary PCa and suggest strategies for genetic evaluation.
Testing without the traditional office visits and counseling poses no additional stress to women.
Expanded testing could increase detection of carriers for BRCA1/2, mutations in other predisposition genes.
Before you discount the results of a DTC genetic test, explore your patient’s reason for undergoing the testing and consider the appropriateness of a referral for medical-grade testing.
Findings support expansion of genetic testing to all women with breast cancer.
A review of the cultural and religious beliefs of Ashkenazi Jewish women that may challenge adherence to breast cancer screening and genetic testing recommendations.
The goal of this study was to determine how molecular features change when PDAC progresses from a primary tumor to metastatic disease.
Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation
